Purchase Short-Term Access

Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications
Veronica Yank, MD; C. Vaughan Tuohy, BS; Aaron C. Logan, MD, PhD; Dena M. Bravata, MD, MS; Kristan Staudenmayer, MD, MS; Robin Eisenhut, BA; Vandana Sundaram, MPH; Donal McMahon, MSc, PhD; Ingram Olkin, PhD; Kathryn M. McDonald, MM; Douglas K. Owens, MD, MS; Randall S. Stafford, MD, PhD
Annals of Internal Medicine 2011;154:529-540. doi:10.7326/0003-4819-154-8-201104190-00004

Purchase Online access to this article for 24 hours
Buy Now

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.